Note! Please note that this article is currently in the "Article in Press" stage and is not the final "Version of record". While it has been accepted, copy-edited, and formatted, however, it is still undergoing proofreading and corrections by the authors. Therefore, the text may still change before the final publication. Although "Articles in Press" may not have all bibliographic details available, the DOI and the year of online publication can still be used to cite them. The article title, DOI, publication year, and author(s) should all be included in the citation format. Once the final "Version of record" becomes available the "Article in Press" will be replaced by that.
[1]
Avian Influenza A(H5N1) - Viet Nam. Available from:
https://www.who.int/emergencies/disease-outbreak-news/item/2024-DON511(accessed on 20- 6-2024)
[2]
Vietnam confirms H5N1 in man's avian flu death. Available from:
https://www.cidrap.umn.edu/avian-influenza-bird-flu/vietnam-confirms-h5n1-mans-avian-flu-death(accessed on 20-6-2024)
[3]
Vietnam sees one avian flu death, warns risk of bird flu spreading to humans. Available from:
https://bhaskarlive.in/vietnam-sees-one-avian-flu-death-warns-risk-of-bird-flu-spreading-to-humans/(accessed on 20-6-2024)
[4]
Stay vigilant with Highly Pathogenic Avian Influenza A(H5N1). Available from:
https://www.fao.org/vietnam/news/detail-events/en/c/1680337/(accessed on 20-6-2024)
[5]
Vietnam detects first human case infected with avian influenza subtype H9. Available from:
https://vietnamnet.vn/en/vietnam-detects-first-human-case-infected-with-avian-influenza-subtype-h9-2267789.html(accessed on 20-6-2024)
[6]
Vietnam reports first avian flu infection in 8 years. Available from:
https://www.cidrap.umn.edu/vietnam-reports-first-avian-flu-infection-8-years(accessed on 20-6-2024)
[7]
First case of A/H9N2 influenza in Vietnam under treatment in HCMC. Available from:
https://en.sggp.org.vn/first-case-of-ah9n2-influenza-in-vietnam-under-treatment-in-hcmc-post109206.html(accessed on 20-6-2024)
[9]
Types of Flu. Available from:
https://www.webmd.com/cold-and-flu/advanced-reading-types-of-flu-viruses(accessed on 20-6-2024)
[10]
Peiris JSM, de Jong MD, Guan Y. Avian influenza virus (H5N1): a threat to human health. Clin Microbiol Rev 2007; 20(2): 243-67.
[http://dx.doi.org/10.1128/CMR.00037-06] [PMID: 17428885]
[http://dx.doi.org/10.1128/CMR.00037-06] [PMID: 17428885]
[11]
Centers for Disease Control and Prevention. Available from:
https://www.cdc.gov/flu/avianflu/spotlights/2023-2024/h5n1-technical-report_april-2024.htm(accessed on 20-6-2024)
[12]
Can bird flu cause the next pandemic? Here’s what doctors say amid concerning rise in H5N1 cases. Available from:
https://www.financialexpress.com/healthcare/news-healthcare/can-bird-flu-cause-the-next-pandemic-heres-what-doctors-say-amid-concerning-rise-in-h5n1-cases/3447646/(accessed on 20-6-2024)
[14]
Vietnam probes human H5 avian flu case. Available from:
https://www.cidrap.umn.edu/avian-influenza-bird-flu/vietnam-probes-human-h5-avian-flu-case( accessed on 13-6-2024)
[15]
Boktor SW, Hafner JW, Doerr C. Influenza (Nursing). In: StatPearls. StatPearls Publishing 2023.
[16]
21-year-old student dies of bird flu in Vietnam. How the disease spreads to humans. Available from:
https://www.moneycontrol.com/news/trends/21-year-old-student-dies-of-bird-flu-in-vietnam-how-the-disease-spreads-to-humans-12526431.html(accessed on 13-6-2024)
[17]
Times now. Available from:
https://www.timesnownews.com/health/vietnam-confirms-first-ever-human-death-from-h5n1-bird-flu-virus-article-108784565(accessed on 13-6-2024)
[19]
Canivet CM, Boursier J. Screening for liver fibrosis in the general population: Where do we stand in 2022? Diagnostics 2022; 13(1): 91.
[http://dx.doi.org/10.3390/diagnostics13010091] [PMID: 36611384]
[http://dx.doi.org/10.3390/diagnostics13010091] [PMID: 36611384]
[20]
European Centre for Disease Prevention and Control. Available from:
https://www.ecdc.europa.eu/en/infectious-disease-topics/z-disease-list/avian influenza/prevention-and-control/antiviral-treatment(accessed on 13-6-2024)
[21]
Malik S, Asghar M, Waheed Y. Outlining recent updates on influenza therapeutics and vaccines: A comprehensive review. Vaccine X 2024; 17: 100452.
[http://dx.doi.org/10.1016/j.jvacx.2024.100452] [PMID: 38328274]
[http://dx.doi.org/10.1016/j.jvacx.2024.100452] [PMID: 38328274]
[22]
He J, Kam YW. Insights from avian influenza: A review of its multifaceted nature and future pandemic preparedness. Viruses 2024; 16(3): 458.
[http://dx.doi.org/10.3390/v16030458] [PMID: 38543823]
[http://dx.doi.org/10.3390/v16030458] [PMID: 38543823]
[23]
Zheng S, Tang L, Gao H, et al. Benefit of early initiation of neuraminidase inhibitor treatment to hospitalized patients with avian influenza A (H7N9) virus. Clin Infect Dis 2018; 66(7): 1054-60.
[http://dx.doi.org/10.1093/cid/cix930] [PMID: 29077848]
[http://dx.doi.org/10.1093/cid/cix930] [PMID: 29077848]
[24]
Li Y, Huo S, Yin Z, et al. The current state of research on influenza antiviral drug development: drugs in clinical trial and licensed drugs. MBio 2023; 14(5): e01273-23.
[http://dx.doi.org/10.1128/mbio.01273-23] [PMID: 37610204]
[http://dx.doi.org/10.1128/mbio.01273-23] [PMID: 37610204]
[25]
Takashita E. Influenza polymerase inhibitors: mechanisms of action and resistance. Cold Spring Harb Perspect Med 2021; 11(5): a038687.
[http://dx.doi.org/10.1101/cshperspect.a038687] [PMID: 32122918]
[http://dx.doi.org/10.1101/cshperspect.a038687] [PMID: 32122918]
[26]
Pitisuttithum P, Boonnak K, Chamnanchanunt S, et al. Safety and immunogenicity of a live attenuated influenza H5 candidate vaccine strain A/17/turkey/Turkey/05/133 H5N2 and its priming effects for potential pre-pandemic use: a randomised, double-blind, placebo-controlled trial. Lancet Infect Dis 2017; 17(8): 833-42.
[http://dx.doi.org/10.1016/S1473-3099(17)30240-2] [PMID: 28533093]
[http://dx.doi.org/10.1016/S1473-3099(17)30240-2] [PMID: 28533093]
[27]
Maartens LH, Frizzo da Silva L, Dawson S, Love N, Erasmus BJ. The efficacy of an inactivated avian influenza H5N1 vaccine against an African strain of HPAI H5N8 (clade 2.3.4.4 B). Avian Pathol 2023; 52(3): 176-84.
[http://dx.doi.org/10.1080/03079457.2023.2181145] [PMID: 37079321]
[http://dx.doi.org/10.1080/03079457.2023.2181145] [PMID: 37079321]
[28]
Belshe RB, Frey SE, Graham I, et al. Safety and immunogenicity of influenza A H5 subunit vaccines: effect of vaccine schedule and antigenic variant. J Infect Dis 2011; 203(5): 666-73.
[http://dx.doi.org/10.1093/infdis/jiq093] [PMID: 21282194]
[http://dx.doi.org/10.1093/infdis/jiq093] [PMID: 21282194]
[29]
Islam MS, Miah M, Hossain ME, Kibria KK. A conserved multi-epitope-based vaccine designed by targeting hemagglutinin protein of highly pathogenic avian H5 influenza viruses. 3 Biotech 2020; 10: 1.: 6.
[30]
Feldman RA, Fuhr R, Smolenov I, et al. mRNA vaccines against H10N8 and H7N9 influenza viruses of pandemic potential are immunogenic and well tolerated in healthy adults in phase 1 randomized clinical trials. Vaccine 2019; 37(25): 3326-34.
[http://dx.doi.org/10.1016/j.vaccine.2019.04.074] [PMID: 31079849]
[http://dx.doi.org/10.1016/j.vaccine.2019.04.074] [PMID: 31079849]